skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group

Borchmann, Peter, Prof ; Haverkamp, Heinz, Dipl-Math ; Lohri, Andreas, MD ; Mey, Ulrich, MD ; Kreissl, Stefanie, MD ; Greil, Richard, Prof ; Markova, Jana, MD ; Feuring-Buske, Michaela, MD ; Meissner, Julia, MD ; Dührsen, Ulrich, Prof ; Ostermann, Helmut, Prof ; Keller, Ulrich, MD ; Maschmeyer, Georg, Prof ; Kuhnert, Georg, MD ; Dietlein, Markus, Prof ; Kobe, Carsten, MD ; Eich, Hans, Prof ; Baues, Christian, MD ; Stein, Harald, Prof ; Fuchs, Michael, MD ; Diehl, Volker, Prof ; Engert, Andreas, Prof

The lancet oncology, 2017-04, Vol.18 (4), p.454-463 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Melanoma epidemiology, biology and prognosis
Melanoma epidemiology, biology and prognosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Melanoma epidemiology, biology and prognosis

Ali, Z ; Yousaf, N ; Larkin, J

European journal of cancer supplements, 2013-09, Vol.11 (2), p.81-91 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Dabrafenib plus trametinib in patients with previously treated BRAFV600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
Dabrafenib plus trametinib in patients with previously treated BRAFV600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dabrafenib plus trametinib in patients with previously treated BRAFV600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

Planchard, David, MD ; Besse, Benjamin, MD ; Groen, Harry J M, Prof ; Souquet, Pierre-Jean, MD ; Quoix, Elisabeth, Prof ; Baik, Christina S, MD ; Barlesi, Fabrice, Prof ; Kim, Tae Min, MD ; Mazieres, Julien, Prof ; Novello, Silvia, MD ; Rigas, James R, MD ; Upalawanna, Allison, PharmD ; D'Amelio, Anthony M, PhD ; Zhang, Pingkuan, MD ; Mookerjee, Bijoyesh, MD ; Johnson, Bruce E, Prof

The lancet oncology, 2016-07, Vol.17 (7), p.984-993 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s
Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s
Material Type:
Artigo 		Adicionar ao Meu Espaço

Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s

Montay-Gruel, Pierre ; Petersson, Kristoffer ; Jaccard, Maud ; Boivin, Gaël ; Germond, Jean-François ; Petit, Benoit ; Doenlen, Raphaël ; Favaudon, Vincent ; Bochud, François ; Bailat, Claude ; Bourhis, Jean ; Vozenin, Marie-Catherine

Radiotherapy and oncology, 2017-09, Vol.124 (3), p.365-369 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

Robert, Caroline, Prof ; Ribas, Antoni, Prof ; Schachter, Jacob, Prof ; Arance, Ana, MD ; Grob, Jean-Jacques, Prof ; Mortier, Laurent, Prof ; Daud, Adil, Prof ; Carlino, Matteo S, MB ; McNeil, Catriona M, MD ; Lotem, Michal, Prof ; Larkin, James M G, Prof ; Lorigan, Paul, Prof ; Neyns, Bart, Prof ; Blank, Christian U, Prof ; Petrella, Teresa M, MD ; Hamid, Omid, MD ; Su, Shu-Chih, PhD ; Krepler, Clemens, MD ; Ibrahim, Nageatte, MD ; Long, Georgina V, Prof

The lancet oncology, 2019-09, Vol.20 (9), p.1239-1251 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
Material Type:
Artigo 		Adicionar ao Meu Espaço

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux

O’Donnell, Jake S ; Massi, Daniela ; Teng, Michele W.L ; Mandala, Mario

Seminars in cancer biology, 2018-02, Vol.48, p.91-103 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Farge, Dominique, MD ; Frere, Corinne, MD ; Connors, Jean M, MD ; Ay, Cihan, MD ; Khorana, Alok A, MD ; Munoz, Andres, MD ; Brenner, Benjamin, MD ; Kakkar, Ajay, MBBS ; Rafii, Hanadi, MD ; Solymoss, Susan, MD ; Brilhante, Dialina, MD ; Monreal, Manuel, MD ; Bounameaux, Henri, MD ; Pabinger, Ingrid, MD ; Douketis, James, MD

The lancet oncology, 2019-10, Vol.20 (10), p.e566-e581 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Dabrafenib in patients with BRAFV600E -positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial
Dabrafenib in patients with BRAFV600E -positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dabrafenib in patients with BRAFV600E -positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

Planchard, David, MD ; Kim, Tae Min, MD ; Mazieres, Julien, Prof ; Quoix, Elisabeth, Prof ; Riely, Gregory, MD ; Barlesi, Fabrice, Prof ; Souquet, Pierre-Jean, MD ; Smit, Egbert F, Prof ; Groen, Harry J M, Prof ; Kelly, Ronan J, MD ; Cho, B C, MD ; Socinski, Mark A, Prof ; Pandite, Lini, MD ; Nase, Christine, BSN ; Ma, Bo, PhD ; D'Amelio, Anthony, PhD ; Mookerjee, Bijoyesh, MD ; Curtis, C Martin, BS ; Johnson, Bruce E, Prof

The lancet oncology, 2016-05, Vol.17 (5), p.642-650 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study
Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study

Gatta, Gemma, MD ; Botta, Laura, MSc ; Rossi, Silvia, MSc ; Aareleid, Tiiu, PhD ; Bielska-Lasota, Magdalena, MD ; Clavel, Jacqueline, MD ; Dimitrova, Nadya, PhD ; Jakab, Zsuzsanna, PhD ; Kaatsch, Peter, MD ; Lacour, Brigitte, MD ; Mallone, Sandra, MSc ; Marcos-Gragera, Rafael, PhD ; Minicozzi, Pamela, PhD ; Sánchez-Pérez, Maria-José, PhD ; Sant, Milena, MD ; Santaquilani, Mariano, IT ; Stiller, Charles, MSc ; Tavilla, Andrea, MSc ; Trama, Annalisa, PhD ; Visser, Otto, PhD ; Peris-Bonet, Rafael, Prof

The lancet oncology, 2014, Vol.15 (1), p.35-47 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Bonvalot, Sylvie, PhD ; Rutkowski, Piotr L, Prof ; Thariat, Juliette, Prof ; Carrère, Sébastien, MD ; Ducassou, Anne, MD ; Sunyach, Marie-Pierre, MD ; Agoston, Peter, MD ; Hong, Angela, MBBS ; Mervoyer, Augustin, MD ; Rastrelli, Marco, MD ; Moreno, Victor, MD ; Li, Rubi K, MD ; Tiangco, Béatrice, MD ; Herraez, Antonio Casado, MD ; Gronchi, Alessandro, MD ; Mangel, László, MD ; Sy-Ortin, Teresa, MD ; Hohenberger, Peter, Prof ; de Baère, Thierry, Prof ; Le Cesne, Axel, MD ; Helfre, Sylvie, MD ; Saada-Bouzid, Esma, MD ; Borkowska, Aneta, MD ; Anghel, Rodica, MD ; Co, Ann, MD ; Gebhart, Michael, Prof ; Kantor, Guy, Prof ; Montero, Angel, MD ; Loong, Herbert H, MD ; Vergés, Ramona, MD ; Lapeire, Lore, MD ; Dema, Sorin, MD ; Kacso, Gabriel, MD ; Austen, Lyn, MD ; Moureau-Zabotto, Laurence, MD ; Servois, Vincent, MD ; Wardelmann, Eva, Prof ; Terrier, Philippe, MD ; Lazar, Alexander J, MD ; Bovée, Judith V M G, Prof ; Le Péchoux, Cécile, MD ; Papai, Zsusanna, Prof

The lancet oncology, 2019-08, Vol.20 (8), p.1148-1159 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (177.843)
  2. Revistas revisadas por pares (163.750)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (176.488)
  2. Book Chapters  (1.854)
  3. Resenhas  (71)
  4. Newsletter Articles  (14)
  5. Livros  (3)
  6. Anais de Congresso  (1)
  7. Dissertações  (1)
  8. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1995  (41)
  2. 1995Até2002  (21)
  3. 2003Até2009  (39.907)
  4. 2010Até2017  (137.672)
  5. Após 2017  (1.503)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (177.920)
  2. Japonês  (12.940)
  3. Espanhol  (499)
  4. Português  (20)
  5. Polonês  (14)
  6. Russo  (11)
  7. Chinês  (8)
  8. Francês  (3)
  9. Alemão  (2)
  10. Norueguês  (1)
  11. Africâner  (1)
  12. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.